Cargando…
Detection of AXL expression in circulating tumor cells of lung cancer patients using an automated microcavity array system
Noninvasive diagnostics using circulating tumor cells (CTCs) are expected to be useful for decision making in precision cancer therapy. AXL, a receptor tyrosine kinase is associated with tumor progression, epithelial‐to‐mesenchymal transition (EMT), and drug resistance, and is a potential therapeuti...
Autores principales: | Ikeda, Mio, Koh, Yasuhiro, Teraoka, Shunsuke, Sato, Koichi, Kanai, Kuninobu, Hayata, Atsushi, Tokudome, Nahomi, Akamatsu, Hiroaki, Ozawa, Yuichi, Akamatsu, Keiichiro, Endo, Katsuya, Higuchi, Masayuki, Nakanishi, Masanori, Ueda, Hiroki, Yamamoto, Nobuyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064033/ https://www.ncbi.nlm.nih.gov/pubmed/31999390 http://dx.doi.org/10.1002/cam4.2846 |
Ejemplares similares
Ejemplares similares
-
Longitudinal Evaluation of PD-L1 Expression on Circulating Tumor Cells in Non-Small Cell Lung Cancer Patients Treated with Nivolumab
por: Ikeda, Mio, et al.
Publicado: (2021) -
Development of an automated size-based filtration system for isolation of circulating tumor cells in lung cancer patients
por: Yagi, Satomi, et al.
Publicado: (2017) -
Comparison of Systemic Inflammatory Response Syndrome and quick Sequential Organ Failure Assessment scores in predicting bacteremia in the emergency department
por: Furuta, Katsuyuki, et al.
Publicado: (2021) -
CD24, not CD47, negatively impacts upon response to PD‐1/L1 inhibitors in non–small‐cell lung cancer with PD‐L1 tumor proportion score < 50
por: Ozawa, Yuichi, et al.
Publicado: (2020) -
Immune‐Related Adverse Events by Immune Checkpoint Inhibitors Significantly Predict Durable Efficacy Even in Responders with Advanced Non‐Small Cell Lung Cancer
por: Akamatsu, Hiroaki, et al.
Publicado: (2019)